Missing
(N=59)
PD-L1 TPS
(N=43)
P-value
Age(years)
Mean (SD) 64.5 (7.34) 63.5 (9.58) 0.551
Median [Min, Max] 66.0 [49.0, 78.0] 63.0 [33.0, 80.0]
Sex
FeMale 6 (10.2%) 5 (11.6%) 1
Male 53 (89.8%) 38 (88.4%)
Smoking
No 18 (30.5%) 14 (32.6%) 0.997
Yes 41 (69.5%) 29 (67.4%)
Pathologic subtype
Non squamous 31 (52.5%) 27 (62.8%) 0.407
Squamous 28 (47.5%) 16 (37.2%)
PFS(months)
Mean (SD) 12.2 (5.55) 15.0 (7.26) 0.362
Median [Min, Max] 12.2 [0.367, 26.3] 14.5 [1.23, 27.9]
OS(months)
Mean (SD) 13.3 (5.81) 16.1 (7.03) 0.42
Median [Min, Max] 14.1 [0.367, 26.3] 16.2 [1.23, 27.9]
Clinical benefit
DCB 51 (86.4%) 38 (88.4%) 0.691
NDB 7 (11.9%) 5 (11.6%)
Unknown 1 (1.7%) 0 (0%)
LDH
Mean (SD) 271 (234) 202 (90.6) 0.302
Median [Min, Max] 199 [96.0, 1660] 174 [111, 518]
Missing 3 (5.1%) 2 (4.7%)
NLR
Mean (SD) 4.40 (2.97) 3.57 (2.34) 0.457
Median [Min, Max] 3.73 [1.17, 16.3] 2.82 [1.15, 14.0]
Missing 1 (1.7%) 1 (2.3%)
Bone metastasis
No 29 (49.2%) 22 (51.2%) 1
Yes 30 (50.8%) 21 (48.8%)
Brain metastasis
No 53 (89.8%) 33 (76.7%) 0.129
Yes 6 (10.2%) 10 (23.3%)
Liver metastasis
No 47 (79.7%) 36 (83.7%) 0.793
Yes 12 (20.3%) 7 (16.3%)
Pleura metastasis
No 41 (69.5%) 30 (69.8%) 1
Yes 18 (30.5%) 13 (30.2%)
Lymph metastasis
No 16 (27.1%) 20 (46.5%) 0.0697
Yes 43 (72.9%) 23 (53.5%)